BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 16126211)

  • 1. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.
    Terrazas LI; Montero D; Terrazas CA; Reyes JL; Rodríguez-Sosa M
    Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential response of antigen presenting cells from susceptible and resistant strains of mice to Taenia crassiceps infection.
    Reyes JL; Terrazas CA; Vera-Arias L; Terrazas LI
    Infect Genet Evol; 2009 Dec; 9(6):1115-27. PubMed ID: 19465163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
    Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
    Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
    Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
    Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
    Wang L; Han R; Hancock WW
    Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y; Starke A; Wüthrich RP
    Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
    Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation.
    del Rio ML; Penuelas-Rivas G; Dominguez-Perles R; Ramirez P; Parrilla P; Rodriguez-Barbosa JI
    Eur J Immunol; 2005 Dec; 35(12):3545-60. PubMed ID: 16285013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism.
    Sugita S; Usui Y; Horie S; Futagami Y; Yamada Y; Ma J; Kezuka T; Hamada H; Usui T; Mochizuki M; Yamagami S
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):263-72. PubMed ID: 18775867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taenia crassiceps infection abrogates experimental autoimmune encephalomyelitis.
    Reyes JL; Espinoza-Jiménez AF; González MI; Verdin L; Terrazas LI
    Cell Immunol; 2011; 267(2):77-87. PubMed ID: 21185554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
    Currie AJ; Prosser A; McDonnell A; Cleaver AL; Robinson BW; Freeman GJ; van der Most RG
    J Immunol; 2009 Dec; 183(12):7898-908. PubMed ID: 20007574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL/6 mice.
    Cao J; Liu FX; Yu MX
    Chin Med J (Engl); 2009 Aug; 122(16):1941-6. PubMed ID: 19781375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.
    Raptopoulou AP; Bertsias G; Makrygiannakis D; Verginis P; Kritikos I; Tzardi M; Klareskog L; Catrina AI; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
    Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ
    Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.
    Agrewala JN; Suvas S; Verma RK; Mishra GC
    J Immunol; 1998 Feb; 160(3):1067-77. PubMed ID: 9570518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.